Xenon Pharmaceuticals Inc (XENE)
40.01
+0.13
(+0.33%)
USD |
NASDAQ |
Apr 22, 16:00
39.99
-0.02
(-0.05%)
After-Hours: 20:00
Xenon Pharmaceuticals Total Return Price: 40.01 for April 22, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
April 22, 2024 | 40.01 |
April 19, 2024 | 39.88 |
April 18, 2024 | 40.31 |
April 17, 2024 | 41.63 |
April 16, 2024 | 41.49 |
April 15, 2024 | 41.31 |
April 12, 2024 | 41.30 |
April 11, 2024 | 42.97 |
April 10, 2024 | 42.43 |
April 09, 2024 | 43.03 |
April 08, 2024 | 42.62 |
April 05, 2024 | 42.25 |
April 04, 2024 | 42.21 |
April 03, 2024 | 41.30 |
April 02, 2024 | 41.47 |
April 01, 2024 | 42.14 |
March 28, 2024 | 43.05 |
March 27, 2024 | 43.00 |
March 26, 2024 | 42.66 |
March 25, 2024 | 42.70 |
March 22, 2024 | 44.00 |
March 21, 2024 | 43.45 |
March 20, 2024 | 43.79 |
March 19, 2024 | 44.35 |
March 18, 2024 | 42.89 |
Date | Value |
---|---|
March 15, 2024 | 43.96 |
March 14, 2024 | 43.67 |
March 13, 2024 | 45.08 |
March 12, 2024 | 44.25 |
March 11, 2024 | 44.37 |
March 08, 2024 | 46.24 |
March 07, 2024 | 46.16 |
March 06, 2024 | 45.96 |
March 05, 2024 | 46.00 |
March 04, 2024 | 45.95 |
March 01, 2024 | 46.84 |
February 29, 2024 | 47.20 |
February 28, 2024 | 47.84 |
February 27, 2024 | 49.63 |
February 26, 2024 | 49.13 |
February 23, 2024 | 49.46 |
February 22, 2024 | 49.25 |
February 21, 2024 | 48.83 |
February 20, 2024 | 48.42 |
February 16, 2024 | 48.91 |
February 15, 2024 | 48.69 |
February 14, 2024 | 48.50 |
February 13, 2024 | 48.06 |
February 12, 2024 | 49.36 |
February 09, 2024 | 50.04 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
8.08
Minimum
Mar 18 2020
50.04
Maximum
Feb 09 2024
24.84
Average
26.16
Median
Jan 28 2022
Total Return Price Benchmarks
Acasti Pharma Inc | 2.85 |
Aurinia Pharmaceuticals Inc | 5.05 |
Edesa Biotech Inc | 4.38 |
Lexaria Bioscience Corp | 2.24 |
ESSA Pharma Inc | 6.40 |